Moderna, Inc. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/01c136b2-a4a6-4871-b8d8-4882a40cea6c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.9B | 2025-01-01 – 2025-12-31 | evidence 0001682852-26-000033 |
| FY 2024 | $3.2B | 2024-01-01 – 2024-12-31 | evidence 0001682852-25-000022 |
| FY 2023 | $6.8B | 2023-01-01 – 2023-12-31 | evidence 0001682852-24-000015 |
| FY 2022 | $19.3B | 2022-01-01 – 2022-12-31 | evidence 0001682852-24-000015 |
| FY 2021 | $18.5B | 2021-01-01 – 2021-12-31 | evidence 0001682852-24-000015 |
| FY 2020 | $803.0M | 2020-01-01 – 2020-12-31 | evidence 0001682852-22-000012 |
| FY 2019 | $60.0M | 2019-01-01 – 2019-12-31 | evidence 0001682852-22-000012 |
| FY 2018 | $135.1M | 2018-01-01 – 2018-12-31 | evidence 0001682852-19-000009 |
| FY 2017 | $205.8M | 2017-01-01 – 2017-12-31 | evidence 0001682852-19-000009 |
| FY 2016 | $108.4M | 2016-01-01 – 2016-12-31 | evidence 0001682852-19-000009 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).